À propos de cet article

Citez

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 2019;157: 107843. Search in Google Scholar

Standards of Medical Care in Diabetes. Summary of revisions. Diabetes Care 2016; 39 (Supplement 1):S4-5. Search in Google Scholar

Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet 2014; 383(9922):1068-83. Search in Google Scholar

Cai X, Xia L, Pan Y, He D, Zhu H, Wei T, et al. Differential role of insulin resistance and β-cell function in the development of prediabetes and diabetes in middle-aged and elderly Chinese population. Diabetol Metab Syndr.. 2019;11:24. Search in Google Scholar

Pala L, Barbaro V, Dicembrini I, Rotella CM. The therapy of insulin resistance in other diseases besides type 2 diabetes. Eat Weight Disord. 2014;19(3):275-83. Search in Google Scholar

Scirica BM. Use of biomarkers in predicting the onset, monitoring the progression, and risk stratification for patients with type 2 diabetes mellitus. Clin Chem. 2017; 63(1):186-195. Search in Google Scholar

Park SE, Park CY, Sweeney G. Biomarkers of insulin sensitivity and insulin resistance: Past, present and future. Crit Rev Clin Lab Sci. 2015;52(4):180-90. Search in Google Scholar

Maruo S, Mori K, Motoyama K, Nakamura M, Kawarabayashi R, Kakutani Y, et al. Correlation analysis of monocyte subsets and insulin resistance considering fetuin-A involvement in patients with type 2 diabetes. Clin Transl Med, 2018;7:9. Search in Google Scholar

Komsa-Penkova RS, Golemanov GM, Radionova ZV, Tonchev PT, Iliev SD, Penkov VV. Fetuin-A - alpha2-heremans-schmid glycoprotein: from structure to a novel marker of chronic diseases part 1. Fetuin-A as a calcium chaperone and inflammatory marker. J Biomed Clin Res. 2017;10(2):90-7. Search in Google Scholar

Ismail NA, Ragab S, El Dayem SM, Elbaky AA, Salah N, Hamed M, et al. Fetuin-A levels in obesity: differences in relation to metabolic syndrome and correlation with clinical and laboratory variables. Arch Med Sci. 2012;8(5):826-33. Search in Google Scholar

Alireza E, Mohsen A, Sahar F, SinaN, Manouchehr N. Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial. Diabetes & Metabolic Syndrome. Clin Res Rev. 2015;9(4):258-65. Search in Google Scholar

Mathews ST, Chellam N, Srinivas PR, Cintron VJ, Leon MA, Goustin AS, et al. Alpha2-HSG, a specific inhibitor of insulin receptor autophosphorylation, interacts with the insulin receptor. Mol Cell Endocrinol. 2000; 164(1-2):87-98. Search in Google Scholar

Pal D, Dasgupta S, Kundu R, Maitra S, Das G, Mukhopadhyay S, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012; 18(8):1279-85. Search in Google Scholar

Oguntibeju OO. Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links. Int J Physiol Pathophysiol Pharmacol. 2019;11(3):45-63. Search in Google Scholar

Ou HY, Yang YC, Wu HT, Wu JS, Lu FH, Chang CJ. Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clin Endocrinol. 2011;75(4):450-455. Search in Google Scholar

Shivakumar. N, Kumar M, Ashwathanarayana M, Venkatesh M, Sheshadri M, Deshmukh S, et al. Role of retinol-binding protein 4 in obese Asian Indians with metabolic syndrome. J Med Biochem. 2012;31(1):40-6. Search in Google Scholar

Khadir A, Kavalakatt S, Madhu D, Hammad M, Devarajan S, Tuomilehto J, et al. Fetuin-A levels are increased in the adipose tissue of diabetic obese humans but not in circulation. Lipids Health Dis. 2018;17(1):291. Search in Google Scholar

Jin C, Lin L, Han N, Zhao Z, Liu Z, Luo S, et al. Effects of dynamic change in fetuin-A levels from the first to the second trimester on insulin resistance and gestational diabetes mellitus: a nested case-control study. BMJ Open Diab Res Care. 2020; 8(1):e000802. Search in Google Scholar

Goustin AS, Abou-Samra AB. The "thrifty" gene encoding Ahsg/Fetuin-A meets the insulin receptor: Insights into the mechanism of insulin resistance. Cell Signal. 2011; 23(6): 980-90. Search in Google Scholar

Bourebaba L, Marycz K. Pathophysiological implication of fetuin-a glycoprotein in the development of metabolic disorders: A concise review. J Clin Med. 2019; 8(12): 2033. Search in Google Scholar

Stefan N, Kantartzis K, Häring HU. Causes and metabolic consequences of Fatty liver. Endocr Rev. 2008; 29(7): 939-60. Search in Google Scholar

Yin L, Cai WJ, Chang XY, Li J, Su XH, Zhu LY, et al. Association between fetuin-A levels with insulin resistance and carotid intima-media thickness in patients with new-onset type 2 diabetes mellitus. Biomed Rep. 2014; 2(6): 839-42. Search in Google Scholar

Yin L, Cai WJ, Zhu LY, Li J, Su XH, Wang XL, et al. Association of plasma Fetuin-A and clinical characteristics in patients with new-onset type 2 diabetes mellitus. Int J Clin Exp Med. 2015; 8(1): 991-9. Search in Google Scholar

Sharma B, Sarmah D. WC is better than BMI as a predictor of diabetes and prediabetes in Hindu priests of India. Asian J Med Sci. 2015; 6(1): 91-4. Search in Google Scholar

Dabrowska AM, Tarach JS, Wojtysiak-Duma B, Duma D. Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015; 159(3): 352-9. Search in Google Scholar

Vörös K, Gráf L, Prohászka Z, Gráf L, Szenthe P, Kaszás E, et al. Serum fetuin-A in metabolic and inflammatory pathways in patients with myocardial infarction. Eur J Clin Invest. 2011; 41: 703-9. Search in Google Scholar

Sun Q, Cornelis MC, Manson JE, Hu FB. Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the US. Diabetes. 2013; 62(1): 49-55. Search in Google Scholar

Song A, Xu M, Bi Y, Xu Y, Huang Y, Li M, et al. Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults. Plos One. 2011; 6(4): e19228. Search in Google Scholar

eISSN:
2956-2090
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Medicine, Clinical Medicine, other